NCT04527874

Brief Summary

This cluster randomized clinical trial at 18 nurse-led rural health centers in Lesotho will test an automated differentiated service delivery model using viral load results, other clinical characteristics and participants' preference to automatically triage participants into groups requiring different levels of attention and care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,809

participants targeted

Target at P75+ for not_applicable hiv-infections

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable hiv-infections

Geographic Reach
1 country

18 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2020

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 27, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

October 14, 2020

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2024

Completed
Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

3.8 years

First QC Date

March 9, 2020

Last Update Submit

July 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Engagement in care with documented viral suppression

    Proportion of participants engaged in care (defined as documented visit attendance) with documented viral suppression (\<50 copies/mL) 24 months (16-28 months) after enrollment

    16-28 months after enrollment

Secondary Outcomes (10)

  • Viral re-suppression

    16-28 months after enrollment

  • Sustained viral suppression

    16-28 months after enrollment

  • Mortality rate

    at 12 and 24 months after enrollment

  • Tuberculosis

    at 12 and 24 months after enrollment

  • Disengagement from care

    at 12 and 24 months after enrollment

  • +5 more secondary outcomes

Other Outcomes (3)

  • Proportion of participants requesting a VL result notification through SMS

    at 24 months after enrollment

  • Proportion of SMS delivered successfully

    at 24 months after enrollment

  • Proportion of participants using the call-back option through District ART Nurse

    at 24 months after enrollment

Study Arms (2)

Intervention

EXPERIMENTAL

Clusters in the intervention arm receive the VITAL intervention (see intervention)

Behavioral: VITAL model

Control

NO INTERVENTION

Clusters in the control arm continue standard of care.

Interventions

VITAL modelBEHAVIORAL

The concept of the VITAL, an automated differentiated service delivery model (aDSDM), is to use viral load results, other clinical characteristics (TB screening results and CD4 cell counts, comorbidities) and participants' preference to automatically triage participants into groups requiring different levels of attention and care. Innovatively, triaging of participants will be done automatically making use of a dedicated mobile App and a viral load database platform. To ensure effective flow of information and empowerment of patients, viral load results and other relevant information is sent directly to participants' phones, whereas health care providers receive results directly on their study tablet together with the recommended action. Further features of the platform are preference-based tailored adherence reminders and automated calls to participants for symptomatic tuberculosis screening.

Also known as: automated differentiated service delivery
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • nurse-led public or missionary clinic in the districts of Butha-Buthe and Mokhotlong;
  • consent of clinic management (signed agreement with clinic management);
  • access to the internet (internet connection must not be constant, but there must be possibility to down- and upload information daily); and
  • the clinic sends plasma VL samples to Butha-Buthe government hospital laboratory for analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (18)

Boiketsiso Health Center

Butha-Buthe, Lesotho

Location

Linakeng Health Center

Butha-Buthe, Lesotho

Location

Makhunoane Health Center

Butha-Buthe, Lesotho

Location

Motete Health Center

Butha-Buthe, Lesotho

Location

Muela Health Center

Butha-Buthe, Lesotho

Location

Ngoajane Health Center

Butha-Buthe, Lesotho

Location

Rampai Health Center

Butha-Buthe, Lesotho

Location

St Paul Health Center

Butha-Buthe, Lesotho

Location

St. Peters Health Center

Butha-Buthe, Lesotho

Location

Tsime Health Center

Butha-Buthe, Lesotho

Location

Libibing

Mokhotlong, Lesotho

Location

Linakaneng health center

Mokhotlong, Lesotho

Location

Malefiloane health center

Mokhotlong, Lesotho

Location

Mapholaneng

Mokhotlong, Lesotho

Location

Moeketsane

Mokhotlong, Lesotho

Location

Molikaliko health center

Mokhotlong, Lesotho

Location

St. James

Mokhotlong, Lesotho

Location

St. Martins

Mokhotlong, Lesotho

Location

Related Publications (2)

  • Tschumi N, Lerotholi M, Kopo M, Kao M, Lukau B, Nsakala B, Chejane N, Motaboli L, Lee T, Barnabas R, Shapiro AE, van Heerden A, Lejone TI, Amstutz A, Brown JA, Heitner J, Belus JM, Chammartin F, Labhardt ND. Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trial. PLoS One. 2022 May 5;17(5):e0268100. doi: 10.1371/journal.pone.0268100. eCollection 2022.

    PMID: 35511950BACKGROUND
  • Harder MT, Mokete M, Chammartin F, Lerotholi M, Motaboli L, Kopo M, Kao M, Mokebe M, Chejane N, Mahlatsi P, Nyakane M, Tarumbiswa T, Labhardt ND, Tschumi N, Belus JM. Cervical cancer screening delay and associated factors among women with HIV in Lesotho: a mixed-methods study. BMC Womens Health. 2024 Oct 1;24(1):543. doi: 10.1186/s12905-024-03382-8.

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Niklaus Labhardt, Prof

    University Hospital, Basel, Switzerland

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: cluster-randomized
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2020

First Posted

August 27, 2020

Study Start

October 14, 2020

Primary Completion

August 7, 2024

Study Completion

August 7, 2024

Last Updated

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

A subset of the key pseudo-anonymised individual participant data collected during the study, along with a data dictionary, will be made available upon request to the Division of Clinical Epidemiology at the University Hospital Basel.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
upon publication of the trial results
Access Criteria
upon request

Locations